In the present study, the tumors in cases NCCLu-237 and NCCLu-253 consisted of an ALK-positive large-cell neuroendocrine carcinoma and an EGFR-mutant squamous cell lung carcinoma, respectively. This evidence concerns the gene ALK and large cell neuroendocrine carcinoma.